Related Experiment Video
Updated: Jun 18, 2026
11:20
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Design of second generation therapeutic recombinant bone morphogenetic proteins
Moulay Hicham Alaoui-Ismaili1, Dean Falb
1Stryker Biotech, Hopkinton, MA 01748, USA. Hicham.alaoui@stryker.com
Cytokine & Growth Factor Reviews
|November 14, 2009
Summary
Next-generation bone morphogenetic proteins (BMPs) are being developed through genetic engineering to improve efficacy and safety for bone repair. These modified BMPs aim to enhance bone formation, reduce costs, and minimize risks associated with current treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Regenerative Medicine
Background:
- Bone morphogenetic proteins (BMPs) are crucial growth factors in the TGF-beta superfamily, with over twenty identified human variants.
- Currently, BMP-2 and BMP-7 (Osteogenic Protein-1) are the only BMPs utilized clinically for spinal fusion and long bone non-union fractures.
- High doses of recombinant BMPs are required for therapeutic efficacy, leading to increased costs and potential safety concerns.
Purpose of the Study:
- To review advancements in genetic engineering for developing second-generation BMPs.
- To explore strategies for enhancing BMP safety and efficacy profiles.
- To provide a perspective on future BMP development.
Main Methods:
- Review of current literature on BMP research and genetic engineering techniques.
- Analysis of modifications aimed at improving BMP characteristics.
- Discussion of potential future directions for BMP development.
Main Results:
- Genetic engineering approaches are being explored to create modified BMPs.
- Potential modifications include enhanced receptor binding, reduced inhibitor sensitivity, improved immunogenicity, and increased solubility/stability.
- These modifications aim to overcome limitations of current recombinant BMP therapies.
Conclusions:
- Second-generation BMPs hold promise for improved therapeutic outcomes in bone regeneration.
- Further research and development are needed to translate these engineered BMPs into clinical practice.
- The next generation of BMPs could offer safer and more cost-effective bone healing solutions.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...